Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28774790 | 0.75 | NOS3 (0.39) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL10591420 | 0.75 | NOS3 (0.39) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL1651152 | 0.75 | NOS3 (0.48) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL30129926 | 0.73 | NPC1 (0.42) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL11907198 | 0.73 | NPC1 (0.42) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL10654837 | 0.72 | NPC1 (0.49) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL28842368 | 0.71 | NOS3 (0.36) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL13700959 | 0.70 | MAPT (0.43) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL18100313 | 0.69 | NPC1 (0.42) | NOS3NOS1NOS2NPC1ALDH1A1 | |
| SCHEMBL12352165 | 0.69 | PRF1 (0.36) | NOS3NOS1NOS2NPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2207750-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC Technology, INC. (US) | 2010-07-21 | — | — | EP | disclosed |
| WO-2009058273-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | EKC TECHNOLOGY, INC. | 2009-04-30 | — | — | US | disclosed |
| US-7491846-B2 | Process for producing hydroxylamine | SHOWA DENKO K.K. (JP) | 2009-02-17 | — | — | US | disclosed |
| US-20080193362-A1 | Process for Producing Hydroxylamine | SHOWA DENKO K.K. (JP) | 2008-08-14 | — | — | US | disclosed |
| EP-1663862-A2 | PROCESS FOR PRODUCING HYDROXYLAMINE | Showa Denko K.K. (JP) | 2006-06-07 | — | — | EP | disclosed |
| WO-2005016817-A2 | PROCESS FOR PRODUCING HYDROXYLAMINE | SHOWA DENKO K. K. (JP) | 2005-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112024-A1 | STABILIZATION OF HYDROXYLAMINE CONTAINING SOLUTIONS AND METHOD FOR THEIR PREPARATION | HNMT, HMOX2, EGLN2 | NOS3 210/4885NOS1 221/4885NOS2 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.